Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the selective loss of motor neurons. Abnormal protein aggregation and impaired protein degradation are believed to contribute to the pathogenesis of this disease. Our previous studies showed that an autophagic flux defect is involved in motor neuron degeneration in the SOD1 G93A mouse model of ALS. Histone deacetylase 6 (HDAC6) is a class II deacetylase that promotes autophagy by inducing the fusion of autophagosomes to lysosomes. In the present study, we showed that HDAC6 expression was decreased at the onset of disease and became extremely low at the late stage in ALS mice. Using lentivirus-HDAC6 gene injection, we found that HDAC6 overexpression prolonged the lifespan and delayed the motor neuron degeneration in ALS mice. Moreover, HDAC6 induced the formation of autolysosomes and accelerated the degradation of SOD1 protein aggregates in the motor neurons of ALS mice. Collectively, our results indicate that HDAC6 has neuroprotective effects in an animal model of ALS by improving the autophagic flux in motor neurons, and autophagosome-lysosome fusion might be a therapeutic target for ALS.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a fatal, adultonset neurodegenerative disease [1] [2] [3] . Pathologically, it is characterized by progressive, selective motor neuron loss in the brain and spinal cord [2, 3] . Mutations in copper/zinc superoxide dismutase (SOD1) account for ~20% of familial cases of ALS [3, 4] . In this study, mice overexpressing the G93A mutation of SOD1 were used to model ALS. The underlying pathogenic mechanisms, although still largely unknown, probably involve the aggregation of misfolded proteins [5, 6] .
There are two main systems for cytoplasmic protein degradation: the ubiquitin-proteasome system and the autophagy-lysosome system [7] . Autophagy is a lysosomebased bulk-degradation pathway to clear misfolded proteins and toxic aggregates. Dysfunction of the autophagylysosome system may contribute to neuronal degeneration in several neurodegenerative diseases [6, 8, 9] . Our previous study and those of others have shown the accumulation of autophagic vacuoles in the spinal cord of SOD1 G93A mice and ALS patients, suggesting a role of autophagy in the pathogenesis of ALS [5, 10] . We further reported that targeting autophagy with rapamycin, a classic autophagy activator, significantly exacerbates motor neuron loss and fails to remove the abnormal mutant SOD1 aggregates, raising the possibility of autophagic flux defects in SOD1 G93A mice [11] .
Our latest study demonstrated that trehalose, an mTOR (mammalian target of rapamycin)-independent autophagy inducer, is able to decrease SOD1 and ubiquitinated protein accumulation as well as improve autophagic flux in the motor neurons of ALS mice, suggesting that the strategy of improving autophagic flux may have potential in ALS treatment [12] .
Histone deacetylase 6 (HDAC6) is a unique class II deacetylase containing a ubiquitin-binding domain; it copes with excessive levels of misfolded proteins by recruiting them to dynein motors for transport to aggresomes [13, 14] .
Furthermore, HDAC6 is a central component of the aggresome that promotes autophagy by inducing the fusion of autophagosomes to lysosomes and regulates the protective response to the formation of cytotoxic protein aggregates [15, 16] . Accumulating evidence has shown that HDAC6-induced autophagy rescues neurons from degeneration in animal models of Huntington's disease, Alzheimer's disease, and Parkinson's disease [17, 18] .
However, little is known about the effects of HDAC6 on ALS.
In this study, we investigated the effects of HDAC6 on motor neuron degeneration in a mouse model of ALS through intracerebroventricular injection of lentivirus-HDAC6 into SOD1 G93A transgenic mice, and explored the underlying mechanisms.
MATERIALS AND METHODS

Mice and Treatments
Transgenic SOD1 G93A mice expressing mutant human SOD1 with a Gly93Ala substitution (B6SJL-Tg-SOD1G93A-1Gur) were originally obtained from Jackson Laboratories The genotypes of the transgenic mice were identifi ed by PCR as in our previous reports [11, 12] . Male SOD1 G93A mice were randomly divided into 2 groups (Tg-Control and 
Plasmids and Clones
Full-length human HDAC6 (NM_006044) was cloned by 
Intracerebroventricular Injection of Lentiviruses
Large-scale lentivirus production and purification were as described previously [19] . In brief, 293FT cells were infected with each lentiviral vector and help vector for viral packaging. After harvesting and shaking, the PEG-800-NaCl system (Sigma-Aldrich, St. Louis, MO) was used to purify and concentrate the lentivirus. The titers of the virus preparation were 6-8 × 10 8 vector genomes per milliliter.
The mice were anesthetized with chloral hydrate and 8 μL 
Behavioral Tests
Assessment of Disease Onset (Rotarod Test)
SOD1
G93A transgenic mice showing disease onset were used for lentivirus injection. Rotarod performance was measured every day in these mice starting at 72 days of age. The date of disease onset was defi ned as when a mouse could not stay on the rotating rod for 5 min [20] . Based on rotarod performance, lentivirus injection was started at 95 days of age. 
Assessment of Lifespan
For lifespan analysis, the date of "death" was defined as the day when a mouse could not right itself within 30 s after being placed on its back [21] . All the mice were tested every day and the date of "death" was recorded.
Immunofl uorescence Staining
Each mouse was anesthetized, perfused with PBS, and 
Slides incubated with secondary antibody Cy2 or Cy3
alone were used as a negative control. In each animal, the images of 20 randomly-selected motor neurons were captured and the number of LC3-or p62-positive puncta in each motor neuron was counted by a researcher who was blinded to the experimental design.
Analysis of Motor Neuron Survival
The fixed L4-5 segments were cut into 10-μm sections, which were Nissl stained with 1% cresyl violet (SigmaAldrich). Every fifth section was selected from the total 250 serial sections from each mouse. The 50 sections from each mouse were photographed under a microscope (Olympus IX81, Tokyo, Japan) and the anterior horns on both sides were examined by a technician who was blinded to the experimental design. The number of motor neurons was counted as described previously [21, 22] .
Immunoblotting
For immunoblotting, 40 mg of lysed protein was separated on SDS-PAGE gel and transferred to PVDF membrane.
Membranes were incubated with the primary antibodies 
Electron Microscopy
Electron microscopy (EM) was performed as reported previously [11, 12] . In brief, L4-5 segments were fixed in 2.5% glutaraldehyde and cut into 50-μm sections. Then, the sections were postfixed in 1% OsO4, dehydrated, embedded, and further cut into 70-nm sections. The ultra-thin sections were stained with uranyl acetate and evaluated with a CM-120 EM (Philips, Eindhoven,
The Netherlands). EM images were captured at a final magnification of 10 000×. Autolysosome was defined as single-membrane structures containing cytoplasmic material and/or organelles [23] .
Statistical Analysis
Kaplan-Meier analysis (SPSS 17.0) was performed for lifespan data and the data were analyzed using the logrank test, generating a χ 2 value to test for significance.
Data of Flag-HDAC6 expression were analyzed using one- (Fig. 1B) . In addition, there was a signifi cant reduction in HDAC6 mRNA levels in the spinal cord of 90-and 120-day-old SOD1 G93A mice compared with age-matched WT mice (Fig. 1C) . These results showed that HDAC6 expression decreases in SOD1 G93A mice at both the transcriptional and translational levels in an age-dependent manner.
To further investigate the expression of lentivirus-HDAC6 in the mouse spinal cord, immunoblotting was used to assess the levels of Flag 2, 4, 6, and 8 weeks after HDAC6 lentivirus injection. The Flag-HDAC6 expression in the spinal cord increased from 2 weeks to 4 weeks after HDAC6 lentivirus injection, then decreased with time ( Fig.   1D , E).
HDAC6 Overexpression Prolonged the Lifespan of
SOD1
G93A Mice
We injected the HDAC6 lentivirus into SOD1 G93A mice at disease onset based on rotarod performance, which was usually at the age of 95 days [11, 12] . We found that Tg-
HDAC6 mice had a 17-day extension in lifespan compared
with Tg-Control mice (140.00 ± 4.33 vs 123.00 ± 2.60, (Fig. 2A) . Moreover, Tg-HDAC6 mice exhibited a signifi cant reduction in body weight loss compared with age-matched Tg-Control mice (Fig. 2B) .
However, there was no difference in body weight between WT-Control and WT-HDAC6 mice.
HDAC6 Overexpression Protected Motor Neurons in
SOD1
G93A Mice
Nissl staining showed a signifi cant loss of motor neurons in the L4-5 segments of 120-day-old SOD1 G93A mice compared with WT mice (Fig. 3A, B) . In addition, the number of motor neurons in the Tg-HDAC6 mice was markedly higher than vs 824.80 ± 42.03, P >0.05) (Fig. 3A, B) .
HDAC6 Overexpression Reduced the Aggregation of LC3-Positive Puncta in Motor Neurons of SOD1 G93A Mice
Previous studies have reported that HDAC6 plays an important role in the process of autophagy [15] . To determine the effect of HDAC6 in this process, we used immunoblotting to determine the LC3-II turnover in the spinal cord of 120-day-old SOD1 G93A mice, and found that HDAC6 overexpression decreased the elevated LC3-II level by ~30.2% (Fig. 4A, B) . Immunofl uorescence staining further revealed a decrease of LC3-positive puncta in the motor neurons of Tg-HDAC6 mice compared with the TgControl mice (Fig. 4C, D) . These results showed that HDAC6 overexpression at disease onset reduces the premature autophagy in the motor neurons of SOD1 G93A mice.
HDAC6 Overexpression Improved Autophagic Flux in
SOD1
G93A Mice
To further investigate the effects of HDAC6 overexpression on autophagic flux, we determined the protein level of p62, a biomarker of autophagic flux [24] , in the spinal cord of SOD1 G93A mice. Immunoblotting showed an abnormally high level of p62 protein in the spinal cord of SOD1 G93A mice compared with WT mice; HDAC6 overexpression reduced the elevated p62 level in the SOD1 G93A mice (Fig.   5A ) by 34.08% (Fig. 5B) . Further, p62 immunostaining showed a signifi cant decrease of p62-positive aggregation in the motor neurons of Tg-HDAC6 mice compared with Tg-Control mice (6.50 ± 1.71 vs 10.25 ± 2.95) (Fig. 5D,   E ). Moreover, EM examination further showed singlemembrane structures of autolysosomes in the motor neurons of Tg-HDAC6 mice (Fig. 5C ), providing more evidence for HDAC6-mediated autophagic protein degradation in SOD1 G93A mice.
We further found a significant decrease in SOD1
aggregates in the Tg-HDAC6 mice compared with the TgControl mice (Fig. 5F ). Analysis showed that the density of SOD1 immunostaining in the motor neurons of Tg-HDAC6 mice was reduced to 66.6% of that in Tg-Control mice (Fig. 5G ).
DISCUSSION
In this study, we first reported that the level of HDAC6 According to previous reports, HDAC6 is highly conserved and the structure and function of mouse HDAC6 are similar to its human ortholog [25, 26] . The double catalytic domain, a ubiquitin-binding domain, and a nuclear export-signal domain are functionally conserved in mouse and human HDAC6, mediating the same deacetylase, [27] . It has been documented that the ubiquitinbinding domain plays an important role in HDAC6-mediated autophagosome maturation and autophagosome-lysosome fusion [14, 15] . In this study, human HDAC6 was selected for overexpression, as it could provide evidence relevant to the clinical treatment of ALS.
Accumulating evidence has suggested that autophagic flux impairment plays a critical role in ALS [28, 29] . Our previous studies showed that the mTOR-dependent autophagic inducer rapamycin accelerates motor neuron loss and aggravates autophagic flux dysfunction in the SOD1 G93A mouse model of ALS [11] . Our latest report provided strong evidence for an autophagic flux defect, especially impairment in the fusion of autophagosomes and lysosomes in the ALS model [12] . In the present study, we found that HDAC6 overexpression after disease onset reduced p62 and SOD1 aggregation, which was accompanied by decreased LC3-positive aggregates in the motor neurons of SOD1 G93A mice. Furthermore, EM analysis showed the formation of autolysosomes in the motor neurons of Tg-HDAC6 mice. Otherwise, a previous study demonstrated that an autophagic protein marker is specifically increased in the spinal motor neurons of SOD1 G93A mice, and not in microglia or astrocytes [11] . In the present study, we further found that the alterations of LC3-II and p62 puncta were mainly in the motor neurons after HDAC6 overexpression in SOD1 G93A mice. These results suggested that HDAC6 improves autophagic flux by inducing the formation of autolysosomes in the motor neurons of ALS mice even at late stages of the disease.
It has been reported that microtubule-based vesicle trafficking, especially the fusion of autophagosomes and lysosomes, is critical for the autophagy process [30] .
And impairment of dynein-mediated trafficking might be associated with the autophagosome-lysosome fusion defect [31] . Mutant SOD1 alters the cellular localization of dynein and inhibits the dynein-mediated trafficking in neurons, which might affect the microtubule-based autophagic fusion step in ALS [32] . HDAC6 acts as a multivalent adapter to bind both ubiquitinated proteins and dynein motors, recruiting misfolded protein cargos to the autophagosomes along the microtubules [14] . It is worth pointing out that HDAC6 stimulates the fusion of autophagosomes to lysosomes and substrate degradation in neurons [15] . Several lines of evidence have documented that HDAC6 defi ciency leads to autophagosome maturation failure, protein aggregation, and neurodegeneration [15, 33] .
On the other hand, expression of HDAC6 at the normal level is sufficient to rescue neurodegeneration in an autophagy-dependent manner [17] . In our study, we found that overexpressing HDAC6 in Tg-HDAC6 mice signifi cantly improved the autophagic fl ux and enhanced the clearance of protein aggregation in motor neurons, further supporting a role of HDAC6 in autophagy-dependent protein degradation in ALS.
Although recent studies have indicated that the induction of HDAC6 can be neuroprotective by removing protein aggregates in neurodegenerative diseases, the therapeutic strategy of targeting HDAC6 is still controversial [33, 34] . Specifi c inhibitors of HDAC6 or genetic knock-down of HDAC6 has shown neuroprotective effects by increasing the acetylation levels of α-tubulin to improve axonal transport in neurons [35, 36] . It is not known whether inhibiting or deleting HDAC6 affects the expression of mutant SOD1 G93A . The variable results may be due to the different functions of HDAC6 at different stages of the disease [37, 38] . It is likely that HDAC6 inhibition at the early stage is beneficial for ALS by restoring axonal transport, while HDAC6 is required to maintain autophagosomelysosome fusion at the later stages of ALS when protein aggregation is dominant in the motor neurons of SOD1 G93A mice. However, more studies are required to explore the detailed mechanisms of HDAC6 activity at different stages of ALS and to investigate the mechanisms underlying the age-dependent decrease of the HDAC6 level in ALS.
In summary, we fi rst report that the level of HDAC6 is significantly decreased at disease onset in the SOD1 G93A mouse model of ALS. HDAC6 overexpression at disease onset prolonged the lifespan and delayed the motor neuron degeneration in ALS mice. Moreover, we found that HDAC6
induced the formation of autolysosomes and accelerated the degradation of SOD1 protein aggregates in the motor neurons of ALS mice. Collectively, these results indicate that HDAC6 is a potential target for ALS treatment.
